More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy

M Flores-Leon, TF Outeiro - Acta neuropathologica, 2023 - Springer
The accumulation of proteinaceous inclusions in the brain is a common feature among
neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease (PD), and …

Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies

US Sandau, SM Magaña, J Costa… - Journal of …, 2024 - Wiley Online Library
Cerebrospinal fluid (CSF) is a clear, transparent fluid derived from blood plasma that
protects the brain and spinal cord against mechanical shock, provides buoyancy, clears …

Lipidomic analysis of adipose-derived extracellular vesicles reveals specific EV lipid sorting informative of the obesity metabolic state

A Blandin, I Dugail, G Hilairet, M Ponnaiah… - Cell reports, 2023 - cell.com
Adipose extracellular vesicles (AdEVs) transport lipids that could participate in the
development of obesity-related metabolic dysfunctions. This study aims to define mouse …

Update on CSF biomarkers in Parkinson's disease

EH Kwon, S Tennagels, R Gold, K Gerwert, L Beyer… - Biomolecules, 2022 - mdpi.com
Progress in develo** disease-modifying therapies in Parkinson's disease (PD) can only
be achieved through reliable objective markers that help to identify subjects at risk. This …

[HTML][HTML] Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments

ME Gegg, E Menozzi, AHV Schapira - Neurobiology of Disease, 2022 - Elsevier
Dysfunction of the endolysosomal system is implicated in the pathogenesis of both sporadic
and familial Parkinson disease (PD). Variants in genes encoding lysosomal proteins have …

Lipid metabolism influence on neurodegenerative disease progression: is the vehicle as important as the cargo?

RE Estes, B Lin, A Khera, MY Davis - Frontiers in molecular …, 2021 - frontiersin.org
Many neurodegenerative diseases are characterized by abnormal protein aggregates,
including the two most common neurodegenerative diseases Alzheimer's disease (AD) and …

[HTML][HTML] Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues

E Menozzi, M Toffoli, AHV Schapira - Pharmacology & therapeutics, 2023 - Elsevier
The GBA1 gene encodes the lysosomal enzyme glucocerebrosidase (GCase), which is
involved in sphingolipid metabolism. Biallelic variants in GBA1 cause Gaucher disease …

GBA-associated PD: chances and obstacles for targeted treatment strategies

G Höglinger, C Schulte, WH Jost, A Storch… - Journal of Neural …, 2022 - Springer
Given the clear role of GBA in the pathogenesis of Parkinson's disease (PD) and its impact
on phenotypical characteristics, this review provides an overview of the current knowledge …

Retinal pigment epithelium extracellular vesicles are potent inducers of age‐related macular degeneration disease phenotype in the outer retina

M Kurzawa‐Akanbi, P Whitfield, F Burté… - Journal of …, 2022 - Wiley Online Library
Age‐related macular degeneration (AMD) is a leading cause of blindness. Vision loss is
caused by the retinal pigment epithelium (RPE) and photoreceptors atrophy and/or retinal …

Circulating sphingolipids and glucose homeostasis: an update

S Ali-Berrada, J Guitton, S Tan-Chen… - International Journal of …, 2023 - mdpi.com
Sphingolipids are a family of lipid molecules produced through different pathways in
mammals. Sphingolipids are structural components of membranes, but in response to …